Bacillus Subtilis Patents (Class 435/839)
  • Patent number: 5728571
    Abstract: A new plasmid vector is described which can replicate in B. subtilis and which can express and secrete, in the culture medium, human beta interleukin-1 (beta IL-1) without amino acid sequences extraneous to the natural molecule, a strain of B. subtilis transformed by the vector and a method for the expression and secretion of mature human beta interleukin-1. The human beta interleukin-1 thus obtained shows a specific acitvity of 1.times.10.sup.9 U/mg of protein and is particularly suitable as a stimulant for the immune system, as an adjuvant in vaccines for the activation of the repair mechanism in cases of tissue damage, and for the treatment of auto-immune diseases in man.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: March 17, 1998
    Assignee: Eniricerche S.p.A.
    Inventors: Ada Velati Bellini, Giuliano Galli, Giuseppe Lucchese, Guido Grandi
  • Patent number: 5674712
    Abstract: A recombinant vector for the expression and secretion of antibodies in single molecule form (scFv) from B. subtilis, where said vector comprises the promoter of the gene for neutral protease, a new secretion sequence (I) and a DNA sequence coding a scFv antibody of interest, a strain of B. subtilis transformed with said recombinant vector, and a process for the exocellular production of scFv antibodies by culturing said strain of B. subtilis are described. The recombinant vector allows the expression of scFv in a completely soluble form and its secretion in high yields.
    Type: Grant
    Filed: March 8, 1994
    Date of Patent: October 7, 1997
    Assignee: Eniricerche S.p.A.
    Inventors: Guido Grandi, Francesca De Ferra, Claudio Tosi, Ornella Tortora, Anna Cuzzoni
  • Patent number: 5672504
    Abstract: A microorganism or a preparation thereof is permitted to act on a mixture of enantiomers of an epoxide such as 3-chlorostyrene oxide and the product optically active epoxide is recovered. The microorganism able to produce an optically active (S)-epoxide from the mixture of enantiomers of the epoxide include, for example, a microorganism strain belonging to the genus Candida, the genus Rhodosporidium, the genus Rhodococcus and the genus Nosardioides. Examples of the microorganism capable of producing an optically active (R)-epoxide from said mixture include a microorganism strain belonging to the genus Trichosporon, the genus Geotrichum, the genus Corynebacterium, the genus Micrococcus and the genus Brevibacterium. The objective optically active epoxide can efficiently be obtained with ease and simplicity from the corresponding mixture of enantiomers of the epoxide.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: September 30, 1997
    Assignee: Daicel Chemical Industries, Ltd.
    Inventors: Akinobu Matsuyama, Yoshinori Kobayashi
  • Patent number: 5667779
    Abstract: A bacterium belonging to Bacillus subtilis and having aflatoxin decomposing ability, as well as a fungal growth inhibitor, fermentation promoter and livestock fattening agent, all containing the bacterium as an active or effective ingredient. The Bacillus subtilis is strain FERM BP-3418. Also disclosed are methods for inhibiting or controlling a pathogenic fungus on a plant or animal.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: September 16, 1997
    Assignee: AHC Inc.
    Inventor: Kazuhiro Kubo
  • Patent number: 5650372
    Abstract: An agriculturally effective active ingredient is applied to plant foliage before, after, or simultaneously with a transport enhancer consisting essentially of B. cereus. ATCC 55675, originally identified as a B. subtilis strain.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: July 22, 1997
    Assignee: Micro Flo Company
    Inventors: Keith L. Branly, Rhett R. Atkins
  • Patent number: 5614375
    Abstract: The invention provides a method for the rapid detection of biotoxic contaants in a test material comprising combining a sample of the test material with activated spores essentially devoid of detectable enzymatic activity, which activity becomes manifest and increases measurably following germination of the spores and with at least one germinant capable of triggering germination of the spores and a substrate which is catalytically convertible to a product by the enzymatic activity, incubating the mixture for a period of less than one hour to accelarate germination of the spores, increase of the enzyme activity, and a catalytic conversion of the substrate, and detecting the formation of the product of the catalytic conversion of the substrate and the enzyme, the level of the product being maximal in the absence of any biotoxic contaminants, and decreasing in direct proportion to the toxicity of contaminants in the test sample.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: March 25, 1997
    Assignee: Yissum Research Development Co. of the Hebrew University of Jerusalem
    Inventor: Nathan Citri
  • Patent number: 5578469
    Abstract: Disclosed are a novel preparation of neotrehalose and its uses. The preparation comprises allowing .alpha.-amylase to act on an amylaceous substance to form neotrehalose, and recovering said neotrehalose. The neotrehalose has a satisfiable chemical stability, as well as other properties such as a sweeteness, energy-imparting ability, osmosis-regulating ability, filler-imparting ability, gloss-imparting ability, moisture-retaining ability, viscosity-imparting ability, crystallization-preventing ability, and non-fermentability. These properties render the neotrehalose advantageously useful in preparations of a variety of compositions.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: November 26, 1996
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Takashi Shibuya, Hiroto Chaen, Shuzo Sakai, Toshio Miyake
  • Patent number: 5549890
    Abstract: A bacterium belonging to Bacillus subtilis and having aflatoxin decomposing ability, as well as a fungal growth inhibitor, fermentation promoter and livestock fattening agent, all containing the bacterium as an active or effective ingredient.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: August 27, 1996
    Assignee: AHC, Inc.
    Inventor: Kazuhiro Kubo
  • Patent number: 5518917
    Abstract: Three strains of a species of Bacillus proteolyticus are provided. This bacterium produces an alkaline protease which is suitable for detergent formulations. The alkaline protease has the amino acid terminal sequence of Seq. ID NO.: 1 as follows: Ala-Gln-Ser-Val-Pro-Trp-Gly-Ile-Ser-Arg-Val-Gln-Ala-Pro-Ala-Ala-His-Asn-Ar g-Gly-. In addition, the alkaline protease has a molecular weight of 28 kdaltons, an isoelectric point from 10-11.5, an optimum pH for proteolytic activity at a pH in the range of 8.5 and 11.5, and retains at least 70% of its original activity after being held at a pH of 8.0 at a temperature of 43.degree. C. for a period of 11 days.
    Type: Grant
    Filed: January 12, 1994
    Date of Patent: May 21, 1996
    Assignee: Solvay Enzymes, Inc.
    Inventors: Ernest W. Boyer, Graham S. Byng
  • Patent number: 5512454
    Abstract: O-acylated cephalosporins are produced by reacting 3-hydroxymethylcephalosporins with an acyl donor containing at least three carbon atoms and an enzyme which is a Rodosporidium toruloides esterase, a wheat germ lipase, an Aspergillus niger lipase, an orange peel acetylesterase or a Bacillus subtilis esterase. A preferred enzyme is the esterase from Rodosporidium toruloides ATCC 10657. The enzyme can be used while in whole cells or in soluble or inmobilized form.
    Type: Grant
    Filed: February 3, 1994
    Date of Patent: April 30, 1996
    Assignee: Bristol-Myers Squibb Company
    Inventors: John J. Usher, Guna Romancik, Michael Politino, David A. Lowe
  • Patent number: 5486467
    Abstract: A microbial catalase having a catalase activity at 0.degree. C. of 95% or more of its catalase activity at 30.degree. C., when measured at pH 7, and a process for producing the same. The microbial catalase preferably has (1) an operative temperature of 0.degree. to 60.degree. C. and an optimum temperature of 0.degree. to 30.degree. C., (2) an optimum pH of 7 to 10, (3) a resistance to 10 mM potassium fluoride, (4) a molecular weight is 65,000.+-.3,000, when measured by SDS polyacrylamide gel electrophoresis, and (5) an isoelectric point is about 4.8, when measured by isoelectric focusing. The catalase is obtainable from Bacillus subtilis IAM 1206 (FERM BP-4844) or a mutant strain thereof.
    Type: Grant
    Filed: December 6, 1994
    Date of Patent: January 23, 1996
    Assignee: Showa Denko Kabushiki Kaisha
    Inventors: Yuichi Fusho, Yoshihiro Yajima
  • Patent number: 5478742
    Abstract: Alkaline Bacillus proteases, their use and a method for producing these proteases are described. These are in particular Bacillus proteases from Bacillus pumilus DSM 5777. The alkaline proteases according to the invention are suitable for use in compositions for cleaning and washing purposes.
    Type: Grant
    Filed: June 16, 1994
    Date of Patent: December 26, 1995
    Assignee: Solvay Enzymes GmbH & Co. KG
    Inventors: Roman Vetter, Detlef Wilke, Bernhard Moeller, Martina Mueller, Ingo Muecke, Meike Takenberg, Gerhard Konieczny-Janda
  • Patent number: 5476773
    Abstract: A flavorant composition is prepared by inoculating and fermenting a protein-rich material, particularly pulse seeds and in particular, cooked pulse seeds, and then, the fermented material is mixed with a reducing sugar and water, the mixture is heated to obtain a reaction product, and the reaction product is dried.
    Type: Grant
    Filed: July 28, 1994
    Date of Patent: December 19, 1995
    Assignee: Nestec S.A.
    Inventors: Sven Heyland, Thang Ho Dac, Hugh Hose, Robert D. Wood
  • Patent number: 5472846
    Abstract: A test kit and method for the amplification and detection of specific antigen cells using a probe. The method includes reacting the probe-specific cells with enzyme-conjugated molecules to form separate molecules. The specific antigen cells are mixed with a selected antibiotic which antibiotic is adversely affected by the enzyme in the reporter molecules and incubating the mixture to promote a bacterial chain reaction forming satellite colonies of bacteria microcolonies about the specific cells which amplifies the cells. The method then includes detecting the amplified probe-specific cells by observing the satellite colonies.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: December 5, 1995
    Inventor: M. Boris Rotman
  • Patent number: 5422256
    Abstract: A strain of Bacillus subtilis which is a tryptophan auxotroph, resistant to sulfaguanidine and flourotryptophan and produces anthranilic acid in a nutrient solution containing L-tryptophan, and process for the preparation of anthranilic acid by fermentation.
    Type: Grant
    Filed: December 28, 1992
    Date of Patent: June 6, 1995
    Assignee: BASF Aktiengesellschaft
    Inventors: Bryan Cooper, Joachim Meyer, Klaus Euler
  • Patent number: 5418146
    Abstract: This invention relates to an improvement in a method for manufacturing dipeptides by coupling N-blocked aspartic acid and a phenylalanine lower alkyl ester in a medium containing a water-miscible organic solvent mixture in the presence of an immobilized metallo-protease so that a continuous reaction is established with stable enzyme activity.
    Type: Grant
    Filed: December 15, 1992
    Date of Patent: May 23, 1995
    Assignee: Miwon Co., Ltd.
    Inventors: Dae K. Joo, Kwang H. Kim, Il Hyun, Min S. Han, Bun S. Lim
  • Patent number: 5371011
    Abstract: Anti-fungal and anti-microbial bacterial strains of Serratia are used in the preparation and preservation of animal feedstuffs made from forage. Bacterial strains of Serratia rubidaea are particularly useful for such purposes, and permit hay to be baled at higher moisture content. Mixtures of this strain with another anti-fungal bacterial, such as Bacillus subtilis, and/or lactic acid-producing bacterial strains, such as strains of Lactobacillus, Streptococcus, Enterococcus, Lactococcus and Pediococcus are used in the preparation and preservation of silage.
    Type: Grant
    Filed: March 30, 1992
    Date of Patent: December 6, 1994
    Assignee: Zeneca Corp.
    Inventors: Roger L. Bernier, Anne-Marie M. LaPointe
  • Patent number: 5371004
    Abstract: The present invention relates to a method and a device for the biological detection of radiation by microorganisms in form of a microorganism coating provided on a sheet substrate, which microorganism coating is exposed, optionally after calibration by exposure to a defined radiation dose, to the radiation to be detected. The principle of evaluating the biologically weighted quantification of the radiation dose consists of photometrically determining the decrease in response to the radiation dose of the amount of synthetically formed products upon selectively staining the biosynthesis products.
    Type: Grant
    Filed: September 2, 1993
    Date of Patent: December 6, 1994
    Assignee: Deutsch Forschungsanstalt fur Luft- und Raumfahrt E.V.
    Inventor: Lothar Quintern
  • Patent number: 5364623
    Abstract: The invention is drawn to an antibiotic produced by Bacillus subtilis ATCC 55422 having a nominal molecular weight of 580 and the empirical formula C.sub.35 H.sub.48 O.sub.7, or a salt thereof. The antibiotic is useful in inhibiting the growth of bacteria, including Escherichia, Klebsiella, Proteus, Serratia, Bacillus and Staphylococcus.
    Type: Grant
    Filed: April 30, 1993
    Date of Patent: November 15, 1994
    Assignee: Bristol-Myers Squibb Company
    Inventors: Pramathesh S. Patel, Friedrich Mayerl, Edward Meyers
  • Patent number: 5364788
    Abstract: A bacterium belonging to Bacillus subtilis. The bacterium being identified as Bacillus subtilis FERM BP-3418. In addition the bacterium possesses the capability of decomposing aflatoxin. It is useful as an active ingredient in products such as a fungal growth inhibitor, fermentation promoter, and livestock fattening agent.
    Type: Grant
    Filed: June 30, 1992
    Date of Patent: November 15, 1994
    Assignee: AHC Inc.
    Inventor: Kazuhiro Kubo
  • Patent number: 5344647
    Abstract: The invention provides Bacillus subtilis strains NCIB 12375, NCIB 12376 and NCIB 12616, which have improved antimicrobial activity. The invention also relates to the use of such strains in the control of microbial infections and microbial contamination.
    Type: Grant
    Filed: December 29, 1992
    Date of Patent: September 6, 1994
    Assignee: Agricultural Genetics Company Limited
    Inventor: Stephen Rossall
  • Patent number: 5334531
    Abstract: The description relates to a plasmid vector expression in Bacillus and used for cloning the structural gene which codes for the human growth hormone, a recombinant DNA molecule comprising plasmid vector and the structural gene of the human growth hormone and a method of preparing the hormone comprising inserting the recombinant DNA molecule into strains of Bacillus and cultivating the resulting transformed strains in a suitable culture environment and recovering the thus-synthesized hormone from the cells.
    Type: Grant
    Filed: February 14, 1992
    Date of Patent: August 2, 1994
    Assignee: Eniricerche S.p.A
    Inventors: Marina Del Bue, Paola Cosmina, Elisabetta Franchi, Guido Grandi
  • Patent number: 5314807
    Abstract: A method of producing an angiotensin converting enzyme inhibitor-containing composition, which is of value as an antihypertensive agent or diet, from natural resources. According to the method, proteins are hydrolyzed with a protease elaborated by a microorganism of the genus Bacillus, Aspergillus or Rhizopus or a protease of papaya origin.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: May 24, 1994
    Assignee: Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha
    Inventors: Masaaki Yoshikawa, Keiichi Yokoyama, Masayasu Hasegawa, Ryouichi Yasumoto, Hiroyuki Fujita
  • Patent number: 5294542
    Abstract: A Bacillus cell containing a mutation in the residual protease III (rp-III) gene resulting in the inhibition of the production by the cell of proteolytically active RP-III.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: March 15, 1994
    Assignee: Omnigene, Inc.
    Inventors: Alan Sloma, Gerald A. Rufo, Jr., Janice Pero
  • Patent number: 5288488
    Abstract: A method of controlling the population of a first microorganism at a foliar locus by preferentially enhancing the population of a second microorganism at said locus, comprises applying to the locus an amount of a durable selective habitat enhancer which substantially preferentially potentiates growth of said second microorganism with respect to said first microorganism. The durable selective habitat enhancer preferably comprises a substantially water-insoluble, weather resistant polymeric substrate and a binder which increases the durability of the habitat enhancer. The second microorganism can be endogenous to the foliar locus or exogenously applied. Chitin and cellulose are preferred habitat enhancers.
    Type: Grant
    Filed: July 8, 1991
    Date of Patent: February 22, 1994
    Assignee: Auburn University
    Inventors: Paul A. Backman, Rodrigo Rodriguez-Kabana, Nancy M. Kokalis
  • Patent number: 5268279
    Abstract: In a fermentive production of polyglutamic acid and a salt thereof, the accumulation of polyglutamic acid can be markedly increased in a very simple manner by adding an alkaline earth metal ion to the medium in a concentration of not less than 0.05 mole per liter.
    Type: Grant
    Filed: July 23, 1990
    Date of Patent: December 7, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Yukihiro Kanegae, Yoshio Sugiyama, Isamu Nakatsui
  • Patent number: 5264363
    Abstract: The present invention relates to a stable mutant of Bacillus subtilis which can produce surfactin with high yields, a method of producing surfactin with the use of the strain and the use of the surfactin obtained for pharmaceutical, energy and environmental problems.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: November 23, 1993
    Assignee: Eniricerche S.p.A.
    Inventors: Paolo Carrera, Paola Cosmina, Guido Grandi
  • Patent number: 5262306
    Abstract: Methods for the isolation and purification of the phytotoxin cercosporin are disclosed as well as methods for identifying microorganisms capable of degrading cercosporin. Cercosporin can be purified from members of the fungal genus Cercospora and incorporated into culture medium for selection of those organisms resistant to cercosporin. Once identified, these organisms can be used to isolate the protein and the gene responsible for conferring cercosporin-resistance. The gene can be cloned and inserted into a suitable expression vector so that the protein can be further characterized. Additionally, the DNA encoding for cercosporin-resistance can be inserted into a vector suitable for transforming an Agrobacterium and the Agrobacterium in turn used to transform plant cells normally susceptible to Cercospora infection. Plants can be regenerated from the transformed plant cells. In this way, a transgenic plant can be produced with the capability of degrading cercosporin.
    Type: Grant
    Filed: April 3, 1990
    Date of Patent: November 16, 1993
    Inventors: David J. Robeson, Mahbubul A. F. Jalal, Robert B. Simpson
  • Patent number: 5244790
    Abstract: The present invention relates to microorgaisms which produce the aroma and flavor of traditional Korean soybean paste. The present invention also relates to a method for producing the soybean paste which comprises inoculating a pure boiled soybean medium with Bacillus subtilis PM3 or Bacillus subtilis SS9 and culturing it at 25.degree.-35.degree. C. for 40-60 days to produce the soybean paste. The present invention further relates to a method for producing the soybean paste, which comprises inoculating a pure boiled soybean medium with Bacillus subtilis PM3 or Bacillus subtilis SS9 together with a fusant yeast ST723-F31 or Bacillus licheniformis SSA3-2M1 and culturing them at 25.degree.-35.degree. C. for 40-60 days to produce the soybean paste.
    Type: Grant
    Filed: December 17, 1991
    Date of Patent: September 14, 1993
    Inventor: Jong K. Kim
  • Patent number: 5225340
    Abstract: The concentration of at least one metal species in an aqueous system is at least reduced in an aqueous system that contains at least one kind of chelating agent, by adding to such system a species or plurality of species of bacteria that have a low toxicity for the metal species, and establishing and maintaining a biomass in the system for a sufficent time period to reduce the metal concentration.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: July 6, 1993
    Assignee: Nalco Chemical Company
    Inventors: Nhuan P. Nghiem, Thomas M. Miller, Richard J. Mouche
  • Patent number: 5223416
    Abstract: A process for the predominantly producing R(-)-mandelic acid or a derivative thereof which comprises subjecting (i) R,S-mandelonitrile or a derivative thereof, or (ii) a mixture of prussic acid and benzaldehyde or a derivative of benzaldehyde to the action of a microorganism selected from the group consisting of the genus Aureobacterium, Pseudomonas, Caseobacter, Alcaligenes, Acinetobacter, Brevibacterium, Nocardia, and Bacillus or treated cells thereof, which the microorganism is capable of stereospecifically hydrolyzing a nitrile group of the R,S-mandelonitrile or a derivative thereof, in a neutral or basic aqueous reaction system to produce the R(-)-mandelic acid.
    Type: Grant
    Filed: March 29, 1991
    Date of Patent: June 29, 1993
    Assignee: Nitto Chemical Industry Co., Ltd.
    Inventors: Takakazu Endo, Koji Tamura
  • Patent number: 5215918
    Abstract: A method for the enantiomeric enrichment of 3-quinuclidinol is disclosed, comprising acid anhydride esterification of the alcohol, followed by preferential enzymatic hydrolysis with a subtilisin protease.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: June 1, 1993
    Assignee: Bend Research, Inc.
    Inventor: David C. Muchmore
  • Patent number: 5202237
    Abstract: This invention relates to operator DNA specific for the repressor of .phi.105 and to the use thereof. The sequence of the operator DNA is 5'-GACGGAAATACAAG-3', 5', GTCGGAAATACAAT-3', 5'-GACGAAATTCAAG-3' or 5'-GTCGTGAATACCAT-3.
    Type: Grant
    Filed: March 15, 1991
    Date of Patent: April 13, 1993
    Assignee: Solvay & Cie
    Inventor: Patrick Dhaese
  • Patent number: 5191063
    Abstract: A method of making a biologically inactive polypeptide active is disclosed. Activity is imparted to the polypeptide through treatment with an exogenous peptide sequence. The nature of the exogenous peptide sequence is disclosed.
    Type: Grant
    Filed: May 2, 1989
    Date of Patent: March 2, 1993
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Masayori Inouye, Yoshiji Ohta, Xueli Zhu, Frank Jordan
  • Patent number: 5182198
    Abstract: A process for preparing (+)-homopilopic acid and the salts thereof which comprises hydrolyzing a mixture of (+)-homopilopic acid ester of the general formula (I): ##STR1## wherein R.sub.1 denotes straight or branched C.sub.1 -C.sub.10 hydrocarbon, and (-)-homopilopic acid ester of the general formula (II): ##STR2## wherein R.sub.2 denotes straight or branched C.sub.1 -C.sub.10 hydrocarbon, in the presence of a microorganism belonging to the genus Arthrobacter, Aspergillus, Escherichia, Cunninghamella, Xanthomonas, Candida, Pseudomonas, Serratia, Cellulomonas, Nocardia, Bacillus, Brevibacterium, Flavobacterium, Mycobacterium, Rhizomucor, Rhodotorula or Rhodococcus, or a treated matter thereof.
    Type: Grant
    Filed: November 16, 1990
    Date of Patent: January 26, 1993
    Assignee: Mitsui Petrochemical Industries, Ltd.
    Inventors: Shoichi Kise, Mikio Hayashida, Aiichiro Ori, Junzou Hiratsuka, Hideaki Yamada
  • Patent number: 5166335
    Abstract: A novel heteropolysaccharide S-184 is disclosed. The compound is a gum produced under suitable conditions by the novel microorganism Alcaligenes sp. This new heteropolysaccharide is composed primarily of carbohydrate as uronic acid (7% to 16%) and mannose, glucose, and galactose in the molar ratio of 1:3:5. The non-carbohydrate portion contains 12-16% protein and 3-4.5% acyl groups. The compound is used to alter viscosity and rheology of aqueous solutions.
    Type: Grant
    Filed: September 4, 1990
    Date of Patent: November 24, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Jerry A. Peik, Suzanna M. Steenbergen, George T. Veeder
  • Patent number: 5118620
    Abstract: A method of transforming eukaryotic or prokaryotic hosts sensitive to an antibiotic of the phleomycin family to confer resistance to the antibiotic is disclosed in which a phleomycin resistance gene is used as a selectable marker.
    Type: Grant
    Filed: March 1, 1991
    Date of Patent: June 2, 1992
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Elise Armau, Daniel Drocourt, Gilles Etienne, Gerard Tiraby
  • Patent number: 5084565
    Abstract: Nucleic acid probes capable of specifically hybridizing to rRNA of E. coli and Shigella species and not to rRNA of non-E. coli/Shigella are described along with methods utilizing such probes for the specific detection of E. coli and/or Shigella in food and other samples.
    Type: Grant
    Filed: August 18, 1988
    Date of Patent: January 28, 1992
    Assignee: Gene-Trak Systems
    Inventors: Kyriaki Parodos, Hsien-Yeh Hsu, David Sobell, Janice M. McCarty, David J. Lane
  • Patent number: 5077063
    Abstract: A process for preparing lactic-acid products which involves fermentation of milk or dairy products with live bacteria, viz. the strain Bacillus subtilis 534 deposited at the All-Union Collection of Microorganisms of the Institute of Biochemistry and Physiology of Microorganisms, the USSR Academy of Sciences and registered under No. B-1666D; the fermentation is conducted until the desired product is obtained.
    Type: Grant
    Filed: December 15, 1989
    Date of Patent: December 31, 1991
    Inventor: Vyacheslav I. Nikitenko
  • Patent number: 5070015
    Abstract: Incubation of 13-deoxy ivermectin aglycone with a species of B. subtilis and of S. griseus results in the production of 13-.beta. ivermectin monoglucopyranoside as the major product and of 5-.beta. ivermectin monoglucopyranoside as the minor product.
    Type: Grant
    Filed: October 15, 1990
    Date of Patent: December 3, 1991
    Assignee: Merck & Co., Inc.
    Inventors: Brian R. Petuch, Shieh-Shung T. Chen, Edward S. Inamine, Raymond F. White
  • Patent number: 5053328
    Abstract: The preparation of an L-amino acid, particularly valine, leucine, isoleucine, alanine and phenylalanine, from the corresponding .alpha.-keto carboxylic acid by bacterial fermentation in the presence of ammonium ions is carried out with the aid of thermophilic Bacillus strains at temperatures above 45.degree. C., in particular above 60.degree. C. Bacillus strains DSM 406, 452, 461, 42, 463, 465 and 466 are particularly suitable for this purpose. The greater solubility of the amino acid at the elevated fermentation temperature permits the separation out of the amino acid from the reaction mixture simply by cooling, whereafter the depleted reaction mixture can be pumped back into the fermenter. Especially favorable yields are achieved by supplying oxygen to the fermenter to an amount of less than about 20% dissolved oxygen.
    Type: Grant
    Filed: September 18, 1986
    Date of Patent: October 1, 1991
    Assignees: Kernforschungsanlage Juelich, Degussa AG
    Inventors: Bernhard Muetze, Christian Wandrey, Wolfgang Leuchtenberger, Toshihisa Ohshima
  • Patent number: 5047239
    Abstract: Preharvest peaches, postharvest apples and postharvest grapes are coated with Bacillus subtilis B-3 to inhibit growth of brown rot, gray mold rot and bitter rot.
    Type: Grant
    Filed: August 11, 1989
    Date of Patent: September 10, 1991
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventor: P. Lawrence Pusey
  • Patent number: 5041377
    Abstract: Crystalline subtilisin is produced by adding a halide salt, such as sodium chloride or calcium chloride, to a concentrated subtilisin solution (at least about 40 g/1). This process does not produce amorphous subtilisin even at high salt concentrations in the solution. Optionally, subtilisin seed crystals also may be added to the concentrate to speed up the crystallization process.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: August 20, 1991
    Assignee: Genencor International Inc.
    Inventors: Todd Becker, Virgil B. Lawlis, Jr.
  • Patent number: 5037758
    Abstract: A B. subtilis strain possessing an enhanced surfactin production potential. The strain is a mutant of B. subtilis ATCC 21332 and has at least one mutation between Arg4 and HisA1 sites of the genetic map of B. subtilis ATCC 21332. Also included in the present invention is B. subtilis strain having the identifying characteristics of ATCC 53813.
    Type: Grant
    Filed: January 11, 1989
    Date of Patent: August 6, 1991
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Catherine N. Mulligan, Terry Y. Chow
  • Patent number: 5036002
    Abstract: Gene expression systems comprising an expression vector and a "trans-acting DNA segment", where the expression vector comprises the gene or genes to be expressed and one or more cis-acting regulatory elements which are responsive to a trans-acting factor produced by said "trans-acting DNA segment". More specifically the invention relates to such gene expression systems where said "trans-acting DNA segment" and said cis-acting regulatory elements comprise one or more segments of the genome from a Bacillus species. Methods for stimulating the production of gene products, vectors for transforming microorganisms, and their use are also disclosed.
    Type: Grant
    Filed: April 17, 1987
    Date of Patent: July 30, 1991
    Assignee: Novo-Nordisk A/S
    Inventor: Sven Hastrup
  • Patent number: 5021340
    Abstract: A description is given of a cloning vector useful for the expression and secretion of heterologous proteins in Bacillus subtilis, molecules of recombinant DNA formed by the said cloning vector, expediently cut at a restriction site located within the neutral protease gene, and by the sequence of heterologous DNA which codes for the protein of interest, Bacillus subtilis cells transformed with the said molecules and capable of expressing the sequence of heterologous DNA and of producing and secreting the protein coded by the said sequence of heterologous DNA in high yields.The proteins obtained in this manner are useful in the fields of pharmaceuticals and foods, or as compounds for the production of substances which are normally obtained by chemical synthesis.
    Type: Grant
    Filed: August 17, 1989
    Date of Patent: June 4, 1991
    Assignee: Eniricerche S.p.A.
    Inventors: Salvatore Toma, Marina Del Bue, Antonio Mele, Guido Grandi
  • Patent number: 5021344
    Abstract: A method of transforming eukaryotic or prokaryotic hosts sensitive to an antibiotic of the phleomycin family to confer resistance to the antibiotic is disclosed in which a phleomycin resistance gene is used as a selectable marker.
    Type: Grant
    Filed: April 30, 1986
    Date of Patent: June 4, 1991
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Elise Armau, Daniel Drocourt, Gilles Etienne, Gerard Tiraby
  • Patent number: 4999301
    Abstract: Microorganisms are stored for long periods of time in storage mediums which preferably contain a sufficiently high concentration of nutrients and growth inhibiting substances to maintain microorganisms, such as bacteria, in the stationary or death phase of their growth cycle. Upon dilution of the growth medium, the concentration of the inhibiting substances is lowered below that inhibiting the growth of the microorganisms, while sufficient nutrients remain to allow for the number of microorganisms to rapidly increase. In a preferred embodiment, the growth medium contains between 10% and 30% solids which are the waste products of a food or fermentation process, and the microorganisms are lactobacillus plantarum or bacillus subtilis.
    Type: Grant
    Filed: September 27, 1988
    Date of Patent: March 12, 1991
    Assignee: 501 United Distillers plc
    Inventor: David G. Bryan-Jones
  • Patent number: 4996055
    Abstract: A deodorant has the genus butyric acid bacteria and the genus Bacillus subtilis as effective components and is used for deodorizing the excrement of various animals and other sources of foul odors. The combined use of the genus butyric acid bacteria and the genus Bacillus subtilis makes it possible to deodorize the sources of foul odors by decomposing hydrogen sulfide, ammonia, mercaptan, etc., contained in the sources of the foul odors.
    Type: Grant
    Filed: April 21, 1989
    Date of Patent: February 26, 1991
    Assignee: Kurasawa Optical Industry Co., Ltd.
    Inventor: Morio Kurasawa
  • Patent number: RE34837
    Abstract: By giving mammals, fowls, fish, etc. feeds containing Bacillus subtilis C-3102 FERM BP-1096), an excellent body weight gain and feed efficiency can be obtained.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: January 24, 1995
    Assignee: The Calpis Food Industry Co., Ltd
    Inventors: Takefumi Iwanami, Kiyoshi Maruta, Ichiya Murota, Hiroshi Miyazaki